tbuckley/cabot-search huggingface dataset:
Management of allergic diseases in pregnancy
Authors: Birgit Pfaller, Sarah Bendien, Agnès Ditisheim, Thomas Eiwegger
Journal: Allergy (2021)

Allergic diseases like asthma, allergic rhinitis, food allergy, hymenoptera allergy, or atopic dermatitis are highly prevalent in women of childbearing age and may affect up to 30% of this age group. This review focuses on the management of allergic diseases during pregnancy. Furthermore, we discuss the challenges of counseling women with allergic diseases in the reproductive age, including considerations relevant to the ongoing SARS-CoV-2 pandemic. To create the optimal milieu for the unborn child, a multitude of immunological changes occur during pregnancy which may favor type 2 responses and aggravate disease phenotypes. In co-occurrence with suboptimal preconception disease control, this elevated Th2 responses may aggravate allergic disease manifestations during pregnancy and pose a risk for mother and child. Due to limitations in conducting clinical trials in pregnant women, safety data on anti-allergic drugs during pregnancy are limited. The lack of information and concerns among pregnant patients demands counseling on the benefits of anti-allergic drugs and the potential and known risks. This includes information on the risk for mother and child of disease aggravation in the absence of treatment. By doing so, informed decisions and shared decision-making can take place.
Cultural adaptation of internet- and mobile-based interventions for mental disorders: a systematic review
Authors: Kerstin Spanhel, Sumeyye Balci, Felicitas Feldhahn, Juergen Bengel, Harald Baumeister, Lasse B. Sander
Journal: npj Digital Medicine (2021)

Providing accessible and effective healthcare solutions for people living in low- and middle-income countries, migrants, and indigenous people is central to reduce the global mental health treatment gap. Internet- and mobile-based interventions (IMI) are considered scalable psychological interventions to reduce the burden of mental disorders and are culturally adapted for implementation in these target groups. In October 2020, the databases PsycInfo, MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Web of Science were systematically searched for studies that culturally adapted IMI for mental disorders. Among 9438 screened records, we identified 55 eligible articles. We extracted 17 content, methodological, and procedural components of culturally adapting IMI, aiming to consider specific situations and perspectives of the target populations. Adherence and effectiveness of the adapted IMI seemed similar to the original IMI; yet, no included study conducted a direct comparison. The presented taxonomy of cultural adaptation of IMI for mental disorders provides a basis for future studies investigating the relevance and necessity of their cultural adaptation.PROSPERO registration number: CRD42019142320.
Effect of Training on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction
Authors: Benjamin J. R. Buckley, Gregory Y. H. Lip, Dick H. J. Thijssen
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
Authors: Pablo A. Olivera, Stephane Zuily, Paulo G. Kotze, Veronique Regnault, Sameer Al Awadhi, Peter Bossuyt, Richard B. Gearry, Subrata Ghosh, Taku Kobayashi, Patrick Lacolley, Edouard Louis, Fernando Magro, Siew C. Ng, Alfredo Papa, Tim Raine, Fabio V. Teixeira, David T. Rubin, Silvio Danese, Laurent Peyrin-Biroulet
Journal: Nature Reviews Gastroenterology & Hepatology (2021)

Abstract Patients with inflammatory bowel disease (IBD) are at increased risk of thrombotic events. Therapies for IBD have the potential to modulate this risk. The aims of this Evidence-Based Guideline were to summarize available evidence and to provide practical recommendations regarding epidemiological aspects, prevention and drug-related risks of venous and arterial thrombotic events in patients with IBD. A virtual meeting took place in May 2020 involving 14 international IBD experts and 3 thrombosis experts from 12 countries. Proposed statements were voted upon in an anonymous manner. Agreement was defined as at least 75% of participants voting as ‘fully agree’ or ‘mostly agree’ with each statement. For each statement, the level of evidence was graded according to the Scottish Intercollegiate Guidelines Network (SIGN) grading system. Consensus was reached for 19 statements. Patients with IBD harbour an increased risk of venous and arterial thrombotic events. Thromboprophylaxis is indicated during hospitalization of any cause in patients with IBD. Disease activity is a modifiable risk factor in patients with IBD, and physicians should aim to achieve deep remission to reduce the risk. Exposure to steroids should be limited. Antitumour necrosis factor agents might be associated with a reduced risk of thrombotic events.
27900 Maintaining long-term improvements in patient-reported symptoms, signs, and quality of life among patients with moderate to severe plaque psoriasis treated with guselkumab: VOYAGE 2, 5-year data
Authors: April W. Armstrong, Kenneth B. Gordon, Lynda Spelman, Kim A. Papp, Chenglong Han, Michael Song, Yin You, Luis Puig, Laura K. Ferris, Kristian Reich
Journal: Journal of the American Academy of Dermatology (2021)
Gasdermin D inhibition prevents multiple organ dysfunction during sepsis by blocking NET formation
Authors: Camila Meirelles S. Silva, Carlos Wagner S. Wanderley, Flavio P. Veras, Fabiane Sonego, Daniele C. Nascimento, Augusto V. Gonçalves, Timna V. Martins, David F. Cólon, Vanessa F. Borges, Verônica S. Brauer, Luis Eduardo A. Damasceno, Katiussia P. Silva, Juliana E. Toller-Kawahisa, Sabrina S. Batah, Ana Letícia J. Souza, Valter S. Monteiro, Antônio Edson R. Oliveira, Paula B. Donate, Daniel Zoppi, Marcos C. Borges, Fausto Almeida, Helder I. Nakaya, Alexandre T. Fabro, Thiago M. Cunha, José Carlos Alves-Filho, Dario S. Zamboni, Fernando Q. Cunha
Journal: Blood (2021)
Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis
Authors: Qi Cui, Kailin Yin, Xiaoting Zhang, Peng Ye, Xianwei Chen, Jianfei Chao, Haowei Meng, Jiangbo Wei, Daniel Roeth, Li Li, Yue Qin, Guihua Sun, Mingzi Zhang, Jeremy Klein, Marvin Huynhle, Cheng Wang, Leying Zhang, Behnam Badie, Markus Kalkum, Chuan He, Chengqi Yi, Yanhong Shi
Journal: Nature Cancer (2021)
Outcome Of Pregnancy After Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Autoimmune Diseases (AD): A Retrospective Study Of The EBMT Autoimmune Diseases Working Party (ADWP)
Authors: Emilian Snarski, John A Snowden, Manuela Badoglio, Kristina Carlson, Joachim Burman, Maria Carolina Oliveira, John Moore, Jeffrey Tan, Montserrat Rovira, Richard E Clark, Albert Saiz, Sondess Hadj Khelifa, Alessandra Crescimanno, Lynne Laing, Maurizio Musso, Thierry Martin, Dominique Farge
Journal: Blood (2013)
Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial
Authors: Lai Wei, Tingting Zhao, Ji Zhang, Qing Mao, Guozhong Gong, Yongtao Sun, Yongping Chen, Maorong Wang, Deming Tan, Zuojiong Gong, Baosen Li, Junqi Niu, Shuchen Li, Huanyu Gong, Liyun Zou, Wei Zhou, Zhengcai Jia, Yan Tang, Lei Fei, Yang Hu, Xiaoyun Shang, Junfeng Han, Bei Zhang, Yuzhang Wu
Journal: Hepatology (2021)

Abstract Background and Aim HBV DNA can be reduced using antiviral drugs in patients with chronic hepatitis B (CHB); however, the rate of HBeAg seroconversion remains low. A clinical trial was conducted to assess the efficacy and safety of a de novo designed liposome‐based nanoparticle lipopeptide vaccine, εPA‐44, for CHB. Approach and Results A two‐stage phase 2 trial, which included a 76‐week, randomized, double‐blind, placebo‐controlled trial (stage 1) and a 68‐week open‐label extension (stage 2), was conducted in 15 centers across China (Clinicaltrials.gov No. NCT00869778). In stage 1, 360 human leukocyte antigen A2 (HLA‐A2)–positive and HBeAg‐positive patients were randomly and equally distributed to receive six subcutaneous injections of 600 µg or 900 µg εPA‐44 or placebo at week 0, 4, 8, 12, 20, and 28. In stage 2, 183 patients received extended 900 µg εPA‐44, and 26 patients were observed for relapse without further treatment. The primary endpoint was the percentage of patients with HBeAg seroconversion at week 76. At week 76, patients receiving 900 µg εPA‐44 achieved significantly higher HBeAg seroconversion rate (38.8%) versus placebo (20.2%) (95% CI, 6.9‐29.6%; p = 0.002). With a combined endpoint of HBeAg seroconversion, alanine aminotransferase normalization and HBV DNA &lt; 2,000 IU/mL, both 900 µg (18.1%) and 600 µg (14.3%), resulted in significantly higher rate versus placebo (5.0%) ( p = 0.002 and p = 0.02, respectively) at week 76. In stage 2, none (0 of 20) of 900 µg εPA‐44‐treated patients experienced serologic relapse. The safety profile of εPA‐44 was comparable to that of placebo. Conclusions Among HLA‐A2‐positive patients with progressive CHB, a finite duration of 900 µg εPA‐44 monotherapy resulted in significantly higher HBeAg seroconversion rate than placebo and sustained off‐treatment effect. A phase 3 trial is ongoing (ChiCTR2100043708).
A Biomimetic In Vitro Model of the Kidney Filtration Barrier Using Tissue‐Derived Glomerular Basement Membrane (Adv. Healthcare Mater. 16/2021)
Authors: Dan Wang, Snehal Sant, Nicholas Ferrell
Journal: Advanced Healthcare Materials (2021)

Glomerular Basement Membranes In article number 2002275 by Nicholas Ferrell and co-workers, a biomimetic tissue culture model of the kidney filtration barrier is developed to evaluate molecular transport. The in vitro filtration barrier model employs kidney-derived glomerular basement membrane to replicate the in vivo microenvironment. The filtration barrier model exhibits molecular selectivity and damage to the basement membrane increases molecular permeability.
Innovative new model predicts glucose levels without poking or prodding
Authors: Leia Wedlund, Joseph Kvedar
Journal: npj Digital Medicine (2021)

With the prevalence of type II diabetes rising rapidly it has become increasingly apparent that something must be done to stem the tide. While pharmaceutical treatments aimed at lowering average blood sugar are an important tool in this endeavor, it is equally (if not more) important to motivate patients to make healthy diet and exercise choices. Recent advances in non-invasive glucose monitoring suggest that real-time patient feedback may soon be available to help guide daily patient decision-making.
25554 An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis treated with ixekizumab from 16 clinical studies
Authors: Luis Puig, Andrew Blauvelt, Michael Ramharter, Arnon Cohen, Wen Xu, Himanshu Patel, Christopher Schuster, Elisabeth Riedl
Journal: Journal of the American Academy of Dermatology (2021)
Stress Echocardiography with Adenosinethreephosphate and Atrial Pacing in Diagnosis of Late Coronary Shunts Stenosis
Authors: A. V. Talanova, D. A. Lezhnev, N. N. Mikheev
Journal: Radiology - Practice (2021)

The aim of the study was to evaluate diagnostic accuracy of stress echocardiography (stress echoCG) with combination of high doze АТР and atrial pacing in diagnosis of late coronary shunts stenosis. 48 men aged from 45 to 64 (48,4 ± 1,6 years), 36 patients undergone mammarocoronary shunting, 12 patients undergone auto venous shunting. Stress echoCG with combination of high doze ATP and atrial pacing suggested shunts lesions in 44 patients, in 8 cases previously intact coronary arteries, approved with coronary angiography. Coronary angiographies reviled no coronary lesions in 24 patients &gt; 70 % shunts restenosis, in 22 coronary stenosis from 50 up to 70 %. Accuracy, sensitivity and specificity of stress- EchoCG with combination of stress-agents in coronary shunts restenosis, as well as stenosis of previously intact coronary arteries were 100 %.
P-124 Nivolumab plus ipilimumab as neoadjuvant therapy for potentially resectable hepatocellular carcinoma
Authors: Y. Su, Y. Lin, C. Hsiao, D. Ou, S. Chen, Y. Wu, W. Lee, J. Lin, C. Hsu, M. Ho, L. Lu, T. Wu, S. Lai, Y. Chao, T. Chou, C. Yen, L. Chen, Y. Shan, A. Cheng, C. Hsu
Journal: Annals of Oncology (2021)
만성 B형 간질환에서 라미부딘 내성의 임상적, 바이러스적 특성
Authors: 김선숙 ( Sun Suk Kim ), 정문기 ( Moon Gi Chung ), 주기탁 ( Ki Tak Ju ), 박동균 ( Dong Kyun Park ), 권오상 ( Oh Sang Kwon ), 구양서 ( Yang Suh Koo ), 김유경 ( Yu Kyung Kim ), 최덕주 ( Duck Ju Choi ), 황유진 ( Yu Jin Hwang ), 김주현 ( Ju Hyun Kim )
Journal: Clinical and Molecular Hepatology (2002)

목적 : B형 간염 바이러스의 증식을 억제하는 라미부딘은 초기 치료효과는 좋으나 장기간 사용시 내성으로 인한 간염의 재발이 문제이다. 본 연구는 라미부딘 치료 중인 만성 B형 간질환자에서 라미부딘 내성의 발생률, 예측인자, 임상 경과 및 약제 내성에 관여한다고 알려진 polymerase 유전자의 변이 양상에 대하여 알아보고자 하였다. 대상과 방법 : 라미부딘을 1일 100mg씩 12개월 이상(평균 15.4개월) 투여한 만성 B형 간질환자 170명(남녀비 3.6:1, 평균연령 38.6세)을 대상으로 하였다. 라미부딘 투여 중 DNA breakthrough가 관찰된 군(이하 내성군)과 DNA breakthrough가 관찰되지 않은 군(이하 비내성군)으로 분류하여, 임상적, 생화학적, 바이러스적 특징과 임상적 경과를 비교하였으며 내성군중 혈청 보관이 가능했던 26예는 치료 전과 내성 발생후 혈청에서 직접 염기순서분석법과 RFLP을 시행하여 YMDD motif를 포함한 polymerase 유전자의 변이양상을 분석하였다. 결과: 1) 라미부딘 약제 내성은 총 170예 중 32예(19%)에서 발생하였고 누적발생률은 12개월에 11%, 24개월에 34%였다. 2) 내성군의 평균연령이 35.6±9.4세로 비내성군의 39.4±9.4에 비하여 유의하게 낮았다(P＜0.05). 평균 투여기간은 내성군이 17.8±3.5개월로 비내성군의 14.93.6개월에 비하여 긴 경향을 보였고 성별, 치료 전 ALT, HBV-DNA치, 알부민, 혈소판치는 두군간의 유의한 차이가 없었다. 치료 전 HbeAg이 양성인 148예 중 32예(22%)에서 내성이 발생하였으나 치료 전 HbeAg이 음성인 경우에는 내성 발생이 한 예도 없었다(p＜0.05). 치료 중 HbeAg이 음정된 47예 중 2예(4%)에서 내성에 발생하였으나 치료 중 HbeAg이 음전되지 않은 101예 중 30예(30%)에서 내성이 발생하여 유의한 차이가 있었다.(p＜0.05). 3) 약제내성과 고나련된 예측인자를 알아 보기 위하여 다변량 분석을 시행하였는데 유의한 예측인자는 없었다(p＞0.05.4) 라미부딘 내성 발생까지의 평균 투여기간은 12.4±3.7개월이었고 내성 발생 후 평균 투여기간은 5.93.5개월이었다.5) 내성군의 임상경과는 ALT치가 치료전보다 높게 상승한 예는 17예(53%)였고 낮게 상승한 예는 13예(41%)였으며 2예(6%)는 ALT의 변화가 없었다. 내성 발생 후 ALT치, HBV DNA치의 변화는 다양하였지만 황달이나 복수 등 비대상성 악화는 관찰되지 않았고 1예에서 라미부딘 내성과 함께 HbeAg이 음전되었다. 6) ploymerase 유전자의 YMDD motif 변이는 26예 중 19예(73%)에서 관찰되었는데 M5521가 13예, M552V+ L528M가 2예, 야생형과의 혼재한 경우가 4예였고 이들은 치료 전 혈청에서는 관찰되지 않았다. YMDD motif외의 다른 부위에서 L547V, 1572V, L577W, E611D, V614I, L615Q, I617L등의 변이가 관찰되었는데 이들은 이들은 치료 전 혈청에서도 관찰되었다. 결론: 1) 라미부딘 내성의 누적발생율은 12개월에 11%, 24개월에 34%였다. 2) 약제내성과 관련된 유의한 예측인자는 없었다. 3) 내성 발생 후 간염의 경과는 다양하였지만 황달이나 복수 등 비대상성악화는 관찰되지 않았다. 4) 라미부딘 내성 시 YMDD motif 변이는 약 73%에서 관찰되었으며, 내성에 관여하는 요인에 대한 연구 및 장기 추적연구가 있어야 할 것이다.
Seeing the Invisible
Authors: Tzyy-Ling Chuang, Yu-Ruei Chen, Yuh-Feng Wang
Journal: Clinical Nuclear Medicine (2021)

ABSTRACT A 76-year-old woman with uterine cervical cancer 20 years ago received right total hip replacement 3 months ago for right hip avascular necrosis without specific intraoperative finding. She reported persistent right hip pain after falling from bed. Pelvic x-ray showed right pubic ramus fracture. To evaluate prosthesis loosening, 99mTc-MDP 3-phase bone scan was arranged, showing diffusely and heterogeneously increased vascularity and tracer perfusion over the right hip, with intensely and heterogeneously increased metabolism in the right iliac bone and hip. SPECT/CT showed nearby swelling of calcified muscles. After debridement and synovectomy, the pathologic report showed chondroblastic osteosarcoma.
カルシウム感知受容体(CaSR)のダウンレギュレーションによる上皮小体(PTG)増殖結鎖への主流としてのサイクリン依存的キナーゼ抑制薬(CDKI)減少
Authors: Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Fukuda K, Hirakata H, Iida M
Journal: Journal of the American Society of Nephrology (2003)
Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals
Authors: Annette Flanagin, Tracy Frey, Stacy L. Christiansen
Journal: JAMA (2021)

The goal of this guidance is to provide recommendations and suggestions that encourage fairness, equity, consistency, and clarity in use and reporting of race and ethnicity in medical and science journals.As previously summarized, "terminology, usage, and word choice are critically important, especially when describing people and when discussing race and ethnicity.Inclusive language supports diversity and conveys respect.Language that imparts bias toward or against persons or groups based on characteristics or demographics must be avoided." 1 With the publication of an earlier version of this guidance, 1 comments were invited, and helpful assessments and comments were received from numerous reviewers, scholars, and researchers, who provided valuable feedback and represented diverse expertise and opinions.After thorough review of these comments (some of which did not agree with others) and additional research and discussion, the guidance was revised and updated, and additional formal review was obtained.In this Editorial, we present the updated guidance, and we sincerely thank the many reviewers for their contributions, each of whom are listed in the Acknowledgment at the end of this article.This guidance continues to acknowledge that race and ethnicity are social constructs as well as the important sensitivities and controversies related to use of these terms and associated nomenclature in medical and health research, education, and practice.Thus, for content published in medical journals, language and terminology must be accurate, clear, and precise, and must reflect fairness, equity, and consistency in use and reporting of race and ethnicity.The guidance also acknowledges that the reporting of race and ethnicity should not be considered in isolation and should be accompanied by reporting of other sociodemographic factors and social determinants, including concerns about racism, disparities, and inequities, and the intersectionality of race and ethnicity with these other factors.The guidance defines commonly used terms associated with race and ethnicity and acknowledges that these terms and definitions have changed, that some are out of date, and that the nomenclature will continue to evolve.Other topics addressed include relevant concerns and controversies in health care and research, including the intersectionality of ancestry and heritage, social determinants of health, and other socioeconomic, structural, institutional, cultural, and demographic factors; reporting of race and ethnicity in research articles; use of racial and ethnic collective or umbrella terms, capitalization, and abbreviations; listing racial and ethnic categories in alphabetical order vs order by majority; adjectival vs noun usage for categories of race and ethnicity; geo-
National, collaborative evaluation of medical student and faculty perspectives on global surgery – Survey of undergraduate respondents on global surgery education (SURGE): A cross-sectional study
Authors: Michal Kawka, Saud Alfadhel, Soham Bandyopadhyay, Vigneshwar R. Veerappan, Won Young Yoon, Hannah S. Thomas, Baveena Heer, Victoria A. Leigh, Luke Y. Zhu, Naomi J. Wright, Angelos G. Kolias, Isobel H. Marks, J Edward Fitzgerald, Kokila Lakhoo, Peter J. Hutchinson, Aayushi Singal, Amir Mohammed, Abirami Kathiravelupillai, Keane Evans-Harvey, Setthasorn ZY. Ooi, Noah Sagua, Chandini P. Chand, Shantanu Bajaj, Payam Soleimani-Nouri, Viraj Shah, Daisy Evans, Sunna Ali, Pedra Rabiee, Alexandrina Braniste, Kurtis Wilson, William J. Doherty, Chloe Jordan, Felecia D'souza, Arina Toma, Rajeevlochan Ravi, Manasi M. Shirke, Teodora-Ioana Pampu-Romanescu, Hira Mayet, Leshanth Uthayanan, Elise Bisson, James R. O'Hanlon, Liza YW. Chong, Mahnoor Shah, Stephen McWilliams, Parivrudh R. Sharma, Rabii Aboulhosn, Conor T. Boylan, Sheryl Abraham, Veena Sudarshan, Felicity Greenfield, Lydia Dean, Manal I. Patel, Sulaymaan Al Majid, Catherine JY. Chaeng, Michael Ashfiel, Eamon Rawlins, Marina Politis, Karisma Sharma, Suraj Gandhi, Oluwatomini Fashina, Biyyam M. Rao, Steven Toh, Aysha Zahid, Xenia Sara, Rand Aljubure, Robert Smillie, Aditi Aggarwal, Himani Jayasinghe, Aqsa Ahmed, Morgan Weiland, Anna Apara, Kiana Bowden, Ali Ridha
Journal: International Journal of Surgery (2021)
Kenneth Roland Kidd
Authors: Paul Barker
Journal: BMJ (2021)

Kenneth Roland Kidd (“Ro”) was in his own modest way a leading light in the development of primary care on the Isle of Wight. Based in Shanklin, he was much loved, and his dedicated support to local families and institutions from 1956 to 1974 was exceptional. He worked tirelessly to provide holistic care to his patients and was recognised by his colleagues, not …
26271 M89, a combination of 89% Vichy volcanic mineralizing water and hyaluronic acid, is an effective adjunct to skin care in management of rosacea
Authors: Enzo Berardesca, Adriana Bonfigli, Bernard Cribier, Frederic Flament, Marco Vicic, Magali Breisse, Emilie Raynaud, Ingrid Durand, Sebastien Grégoire, Delphine Kerob, Jerry Tan
Journal: Journal of the American Academy of Dermatology (2021)
27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis
Authors: Bardur Sigurgeirsson, Knut Schäkel, Chih-Ho Hong, Isaak Effendy, Waldemar Placek, Phoebe Rich, Gerard Bruin, Pascal Charef, Rong Fu, Isabelle Hampele, Manmath Patekar
Journal: Journal of the American Academy of Dermatology (2021)
Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease
Authors: Diana M. Lopez, Sanjay Divakaran, Ankur Gupta, Navkaranbir S. Bajaj, Michael T. Osborne, Wunan Zhou, Jon Hainer, Courtney F. Bibbo, Hicham Skali, Sharmila Dorbala, Viviany R. Taqueti, Ron Blankstein, Marcelo F. Di Carli
Journal: JACC. Cardiovascular imaging (2021)